Response of T lymphocyte populations in prostate cancer patients undergoing radiotherapy: Influence of neoajuvant total androgen suppression

Anticancer Research

Volumn 25, Issue 4, 2005, Pages 3159-3166

  Johnke, Roberta M ^a   Edwards, Judy M ^a   Kovacs, Charles J ^a   Evans, Mark J ^a   Daly, Barbara M ^a   Karlsson, Ulf L ^a   Lee, Tung Kwang ^a   Allison, Ron R ^a   Arastu, Hyder H ^a   Cariveau, Mickael J ^a   O'Brien, Kevin F ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Antiandrogen therapy; Flow cytometry; Lymphocytes; Prostate cancer; Radiotherapy

Indexed keywords

ANDROGEN; FLUTAMIDE; GOSERELIN; TESTOSTERONE;

ADULT; AGED; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER STAGING; CELL POPULATION; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HELPER CELL; HUMAN; IMMUNOMODULATION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROSTATE CANCER; SUPPRESSOR CELL; T LYMPHOCYTE;

AGED; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FLUTAMIDE; GOSERELIN; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROSTATIC NEOPLASMS; T-LYMPHOCYTES;

EID: 22944485041     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Lawton CA, Winter K, Byhardt R, Sause WT, Hanks GE, Russell AH, Rotman M, Porter A, McGowan DG, DelRowe JD and Pilepich MV: Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 38: 931-939, 1997.
2. Zietman AL, Prince EA, Nakfoor BM and Shipley WU: Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: experimental and clinical results. Urology 49(3A Suppl): 74-83, 1997.
3. Roach M 3rd: Neoadjuvant therapy prior to radiotherapy for clinically localized prostate cancer. Eur Urol 32(Suppl 3): 48-54, 1997.
4. Zietman AL: The case for neoadjuvant androgen suppression before radiation therapy. Mol Urol 4: 203-208, 2000.
5. DeWeese TL and Song DY: Current evidence for the role of combined androgen suppression and radiation in the treatment of adenocarcinoma of the prostate. Urology 55: 169-174, 2000.
6. McLeod DG and Moul JW: Controversies in the treatment of prostate cancer with maximal androgen deprivation. Surg Oncol Clin N Am 4: 345-359, 1995.
7. Ablin RJ, Bartkus JM and Gonder MJ: In vitro effects of diethylstilbestrol and the LHRH analogue leuprolide on natural killer cell activity. Immunopharmacology 15: 95-101, 1988.
8. Ablin RJ, Bhatti RA and Guinan PD: Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate. Cancer Res 38: 3702-3706, 1978.
9. Ablin RJ, Gonder MJ and Bartkus JM: Leuprolide vs. diethylstilboestrol: effect on natural killer cells. Anticancer Res 8: 73-76, 1988.
10. Bakerman S: In: ABC's of Interpretive Laboratory Data. 2nd edition, Greenville (NC): Interpretive Laboratory Data, Inc., pp. 444, 1984.
11. Blomgren H, Edsmyr F, Esposti PL and Naslund I: Spontaneous cytotoxicity of blood lymphocytes following local radiation therapy for carcinoma of the urinary bladder. Acta Radiol Oncol 22: 145-150, 1983.
12. Blomgren H, Edsmyr F, Naslund I, Petrini B and Wasserman J: Distribution of lymphocyte subsets following radiation therapy directed to different body regions. Clin Oncol 9: 289-298, 1983.
13. Clave E, Socie G, Cosset JM, Chaillet MP, Tartour E, Girinsky T, Carosella E, Fridman H, Gluckman E and Mathiot C: Multicolor flow cytometry analysis of blood cell subsets in patients given total body irradiation before bone marrow transplantation. Int J Radiat Oncol Biol Phys 33: 881-886, 1995.
14. De Ruysscher D, Waer M, Vandeputte M, Aerts R, Vantongelen K and van der Schueren E: Changes of lymphocyte subsets after local irradiation for early stage breast cancer and seminoma testis: long-term increase of activated (HLA-DR+) T cells and decrease of "naive" (CD4-CD45R) T lymphocytes. Eur J Cancer 28A: 1729-1734, 1992.
15. Louagie H, Van Eijkeren M, Philippe J, Thierens H and De Ridder L: Changes in peripheral blood lymphocyte subsets in patients undergoing radiotherapy. Int J Radiat Biol 75: 767-771, 1999.
16. Hertveldt K, Philippe J, Thierens H, Cornelissen M, Vral A and DeRidder L: Flow cytometry as a quantitative and sensitive method to evaluate low dose radiation induced apoptosis in vitro in human peripheral blood lymphocytes. Int J Radiat Biol 71: 429-433, 1997.
17. Louagie H, Cornelissen M, Philippe J, Vral A, Thierens H and De Ridder L: Flow cytometric scoring of apoptosis compared to electron microscopy in gamma irradiated lymphocytes. Cell Biol Int 22: 277-283, 1998.
18. Philippe J, Louagie H, Thierens H, Vral A, Cornelissen M and De Ridder L: Quantification of apoptosis in lymphocyte subsets and effect of apoptosis on apparent expression of membrane antigens. Cytometry 29: 242-249, 1997.
19. Maity A, McKenna WG and Muschel RJ: The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother Oncol 31: 1-13, 1994.
20. Szumiel I: Ionizing radiation-induced cell death. Int J Radiat Biol 66: 329-341, 1994.
21. Newman GH, Rees GJ, Jones RS, Grove EA and Preece AW: Changes in helper and suppressor T lymphocytes following radiotherapy for breast cancer. Clin Radiol 38: 191-193, 1987.
22. Reckzeh B, Merte H, Pfluger KH, Pfab R, Wolf M, Haverman K: Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer. J Clin Oncol 14: 1071-1076, 1996.
23. Rotstein S, Blomgren H, Petrini B, Wasserman J and Baral E: Long term effects on the immune system following local radiation therapy for breast cancer. I. cellular composition of the peripheral blood lymphocyte population. Int J Radiat Oncol Biol Phys 11: 921-925, 1985.
24. Wolf GT, Amendola BE, Diaz R, Lovett EJ, Hammerschmidt RM and Peterson KA: Definite vs adjuvant radiotherapy. Comparative effects on lymphocyte subpopulations in patients with head and neck squamous carcinoma. Arch Otolaryngol 111: 716-726, 1985.
25. Marchetti B, Guarcello V, Morale MC, Bartoloni G, Raiti F, Palumbo G Jr, Farinella Z, Cordaro S and Scapagnini U: Leutinizing Hormone-Releasing Hormone (LHRH) agonist restoration of age-associated decline of thymus weight, thymic LHRH receptors, and thymocyte proliferative capacity. Endocrinology 125: 1037-1045, 1989.
26. McMurray RW, Suwannaroj S, Ndebele K, Jenkins JK: Differential effects of sex steroids on T and B cells: modulation of cell cycle phase distribution, apoptosis and bcl-2 protein levels. Pathobiology 69: 44-58, 2001.
27. Olsen NJ and Kovacs WJ: Effects of androgens on T and B lymphocyte development. Immunol Res 23: 281-288, 2001.
28. Olsen NJ and Kovacs WJ: Gonadal steroids and immunity. Endocr Rev 17: 369-384, 1996.
29. Olsen NJ, Viselli SM, Fan J and Kovacs WJ: Androgens accelerate thymocyte apoptosis. Endocrinology 139: 748-752, 1998.